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REGULAR ARTICLE
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Although there is recent evidence that cells from the periph-
eral immune system can gain access to the central nervous 
system in certain conditions such as multiple sclerosis, their 
role has not been assessed in psychosis. Here, we aimed to 
explore whether blood cell count was associated with brain 
volume and/or clinical symptomatology. A total of 218 par-
ticipants (137 first-episode psychosis patients [FEP] and 
81 healthy controls [HC]) were included in the study. For 
each participant, a T1 structural image was acquired, from 
which brain tissue volumes were calculated. We found that, 
in FEP, neutrophil count was associated with reduced gray 
matter (GM) volume (β = −0.117, P < .001) and increased 
cerebrospinal fluid volume (β = 0.191, P = .007). No associ-
ations were observed in HC. GM reduction was generalized 
but more prominent in certain regions, notably the thala-
mus, the anterior insula, and the left Heschl’s gyrus, among 
many others. Neutrophil count was also associated with the 
total PANSS score (β = 0.173, P = .038), including those 
items assessing hallucinations (β  =  0.182, P  =  .028) and 
avolition (β = 0.197, P = .018). Several confounders, such 
as antipsychotic medication, body mass index, and smoking, 
were controlled for. Overall, the present study may represent 
the first indirect evidence of brain tissue loss associated with 
neutrophils in psychosis, and lends support to the hypothesis 
of a dysregulated immune system. Higher neutrophil count 
was also associated with more severe clinical symptomatol-
ogy, which renders it a promising indicator of schizophrenia 
severity and could even give rise to new therapies.
Key words: neuroimmunology/structural neuroimaging/ 
leucocytes/hallucinations/avolition
Introduction
Despite it being one of the most devastating mental dis-
orders, we are still far from knowing what factors are 
responsible for the beginning of schizophrenia and related 
disorders. One of the most promising theories proposes 
that the immune system is involved in the etiology of the 
disease, either due to immunological alterations or auto-
immune mechanisms. In fact, there is a vast number of 
studies that have examined abnormalities in microglia,1 the 
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first immunological defense of the central nervous system, 
in schizophrenia. However, data from postmortem stud-
ies have not yielded consistent results1; while some studies 
have found increased microglial cells in patients with schiz-
ophrenia,2–4 others have not found differences between 
patients and healthy participants.5,6 Similarly, while some 
studies have found differences in microglial activation 
between patients with schizophrenia and healthy controls 
(HCs), the most recent research contradicts previous find-
ings.1 Furthermore, some research has focused on cyto-
kines, which are small proteins that regulate inflammatory 
responses.7 In this regard, several cytokines have consist-
ently been shown to be increased in schizophrenia.8,9
Although available evidence is still controversial, it is 
plausible to think of an association between immunologi-
cal factors and schizophrenia; however, not much research 
on the mechanisms by which the immunological alterations 
may affect the schizophrenic brain has been conducted. 
Kenk et al10 did not find an association between microglial 
activation and the volume of some brain regions such as 
the hippocampus and the prefrontal cortex. The rest of the 
evidence available in this respect comes from studies that 
have analyzed either microglial activation or brain struc-
tural changes, but not both in the same sample; while in 
certain regions microglia seem to be related to structural 
changes, results are inconsistent and no conclusive evidence 
has been assembled.1 Additionally, some recent studies 
have reported a relationship between cytokines and brain 
structure. Cannon et al11 reported an association between 
inflammatory cytokines and prefrontal cortical thinning 
in patients at clinical high risk who converted to psycho-
sis. In schizophrenia, higher levels of inflammatory cyto-
kines have been found associated with reduced volume of 
some brain areas that were previously selected as regions of 
interest, such as Broca’s area12 and total cortical gray matter 
(GM) and superior frontal gyrus in a postmortem study.13
The role of the white blood cells (leucocytes), which 
form the peripheral immune system and are crucial in 
inflammatory processes, has been laid aside in the context 
of brain structural changes in schizophrenia. The fact that 
the blood–brain barrier (BBB) restricts the entrance of 
peripheral immune cells to the brain may explain this lack 
of interest. However, there is now increasing evidence that, 
under certain pathological conditions, the BBB may be dis-
rupted and allow peripheral blood cells to enter the brain, 
as has been observed in multiple sclerosis (MS) and after 
stroke.14 Importantly, it has been suggested that BBB may 
also be disrupted in schizophrenia.15 So far, several studies 
have addressed the effects of leucocytes on an injured cen-
tral nervous system. For an extensive review of this topic, 
see Gadani et al.16 For example, neutrophils appear to exert 
destructive actions in the cerebral tissue after they infil-
trate the brain, as has been reported in an animal model of 
traumatic brain injury.17 Similarly, in humans that have suf-
fered a stroke, neutrophil infiltration into the brain seems 
to be associated with larger infarct volumes and worse 
outcomes.18 More controversy exists regarding monocytes 
and lymphocytes;16 monocytes, for example, have been 
reported to cause neuronal damage in mice with induced 
seizures,19 but also to protect the brain after a stroke.20 
In the case of lymphocytes, most of the research points 
predominantly to their protective effects in the brain,16 
as shown for instance by Marsh et al,21 who reported an 
accelerated progression in a mouse model of Alzheimer’s 
disease (AD) that lacked lymphocytes. However, whether 
lymphocytes have beneficial or detrimental effects after a 
stroke is still not clear.22 Given that first-episode psycho-
sis (FEP) patients present a progressive loss of GM vol-
ume,23 it could be hypothesized that brain tissue loss may 
be due to the deleterious effects of peripheral white blood 
cells on the central nervous system. Therefore, we aim to 
investigate whether or not white blood cells are implicated 
in schizophrenia, and, if so in what manner. In addition 
to leucocytes, erythrocytes24 and platelets25 seem to play a 
part on immunity and will also be explored.
Here, we report a thorough analysis of whether and 
how blood cells are associated with brain volume in 
FEP patients and in HC participants. We employed a 
relatively large sample and a whole-brain approach to 
detect potential effects in an unbiased manner. First, we 
sought for differences between FEP and HC in regard to 
brain volume and blood cell count. Second, we examined 
whether any type of blood cell was associated with GM, 
white matter (WM), and cerebrospinal fluid (CSF) vol-
umes in FEP and HC, and which specific brain regions 
were involved. Finally, we explored potential associations 
between blood cells and clinical symptomatology.
Methods
Participants
A total of 218 participants, 137 FEP patients and 81 HC 
participants, were selected from the larger sample of the 
PEPs study26 if  they were aged 13 or older, had a T1 struc-
tural image of the brain, a blood sample, and all the dem-
ographic and clinical data available. Detailed information 
on how participants were recruited, inclusion/exclusion 
criteria, and ethical statements are available in the sup-
plementary material.
Neuroimaging Data Acquisition, Processing, and 
Analysis
A high-resolution T1-weighted structural image was 
obtained for each participant, who were scanned in 1 
of the 5 scanners available for the PEPs study. Detailed 
information on data acquisition is available in the supple-
mentary material. All neuroimaging data were processed 
and analyzed with SPM12 (Wellcome Department of 
Imaging Neuroscience, London; www.fil.ion.ucl.ac.uk/
spm) running under MATLAB (Release 2012b, The 
MathWorks, Inc.). GM, WM, and CSF were segmented 
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for each participant employing the CAT12 toolbox (http://
www.neuro.uni-jena.de/cat). We ensured that the images 
employed for the segmentation were of good quality by 
means of the internal tool provided by CAT12 to this 
end. The modulated and warped GM segments (“mwp1” 
files) derived from the segmentation were smoothed using 
a Gaussian kernel of 12 mm full-width-at-half-maximum 
and employed in the whole-brain voxel-based morphome-
try (VBM) analyses described in the “Statistical analysis” 
section. Additionally, the volume of specific brain struc-
tures was automatically calculated after the segmentation 
using the Neuromorphometrics atlas (http://www.neu-
romorphometrics.com). Total brain volume (TBV) was 
obtained from the sum of GM, WM, and CSF volumes.
Blood Sampling
Blood extraction was carried out in the baseline visit, and 
2 months, 6 months, 1 year, and 2 years after the base-
line visit. All blood samples were collected between 8:00 
and 10:00 am after an overnight fast. Since not all blood 
extractions and neuroimaging scans were carried out on 
the same day, blood cell count was derived either from 
the baseline or 2-month-visit blood sample according to 
the criteria presented in the supplementary material. The 
median days of difference between blood sampling and 
MRI were 14.5 for FEP and 17 for HC.
Demographic and Clinical Data
Information regarding age, sex, years of education, and 
body mass index (BMI) was collected for all the par-
ticipants. The Positive and Negative Syndrome Scale 
(PANSS)27 and the Symptom Onset in Schizophrenia 
scale (SOS)28 were administered to FEP patients.
Medication and Substance Use
We collected information about the cumulative amount 
of antipsychotic medication taken daily by FEP patients, 
from the first day of medication until the day on which 
the blood extraction was carried out, as well as whether 
they were taking other psychotropic medications, namely 
anxiolytics, antidepressants, lithium, other mood stabiliz-
ers, and biperiden. Nonantipsychotic medication intake 
was required to start at least 1 week before the blood 
extraction to be considered. Moreover, the number of 
cigarettes of tobacco and/or cannabis smoked daily by all 
the participants was also recorded. Detailed information 
on how the amount of antipsychotic medication was cal-
culated is available in the supplementary material.
Backward Elimination With Bootstrap Resampling 
Procedure
Aiming to determine which blood cell type was most sig-
nificantly associated with our variables of interest (brain 
volume and clinical symptomatology), we employed 
a statistical procedure which combines the backward 
elimination method with bootstrap resampling, as pro-
posed by Austin and Tu.29 For each variable of interest, 
some predictors were tested, including the 7 blood cell 
type counts and several sociodemographic and clinical 
covariates. The backward elimination method was used 
in each bootstrap sample to generate a predictive model. 
This procedure was carried out automatically with the 
boot.stepAIC function (https://www.rdocumentation.
org/packages/bootStepAIC/versions/1.2-0/topics/boot.
stepAIC) of the R software (https://www.r-project.org). 
Later on, we determined the frequency with which each 
predictor was identified as significantly associated with 
the variable of interest. Following Austin and Tu,29 some 
candidate models were then generated according to the 
frequency with which each variable was selected. Linear 
regression analyses were then conducted to test these 
candidate models. The first model to be tested was the 
one including the most frequently selected blood cell 
type, along with those covariates selected in all the boot-
strap samples. Next, covariates selected in at least 90% 
of the bootstrap samples were added to the model to 
see if  the previous one was significantly improved. This 
was repeated with the covariates selected in at least 80%, 
70%, 60%, and 50% of the bootstrap samples. If  a model 
significantly improved the previous one but one or more 
of the variables included in it were nonsignificant, these 
variables were removed and the remaining model was re-
tested again. Eventually, this allowed us to identify the 
most parsimonious model. Finally, the rest of the blood 
cells were added, one at a time, to the final model to check 
whether the model fit was significantly improved.
Statistical Analysis
First, comparisons between FEP and HC regarding dem-
ographic and clinical data were conducted. Brain tis-
sue volumes and blood cell count were also compared 
between FEP and HC with ANCOVAs controlling for 
age, sex, TBV, and years of education where appropriate. 
Second, the backward elimination with bootstrap resa-
mpling procedure explained above was conducted with 
GM, WM, and CSF volumes as dependent variables, 
and the 7 blood cell type counts (neutrophils, eosino-
phils, basophils, lymphocytes, monocytes, erythrocytes, 
and platelets), along with age, sex, years of education, 
TBV, antipsychotic medication, tobacco smoking, can-
nabis smoking, and BMI, as predictors. A  whole-brain 
multiple regression VBM analysis was then conducted 
on GM tissue, including as predictors those variables 
that were identified as significantly associated with GM 
volume in the model-generating procedure. An absolute 
threshold masking corresponding to 20% tissue probabil-
ity was employed, aiming to rule out voxels with a low 
probability of actually representing GM. An uncorrected 
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voxel-level cluster defining threshold P <.001 and a fam-
ily wise error-corrected cluster-level threshold P <.05 
were employed. A less-restrictive VBM analysis, employ-
ing an uncorrected voxel-level cluster defining threshold 
P <.001, without further correction for multiple com-
parisons, was conducted to identify brain regions likely 
to show global, rather than localized, effects. The whole 
volume of these brain regions, along with the whole vol-
ume of lateral, third, and fourth ventricles, were calcu-
lated and included in linear regression analyses, including 
as predictors those variables previously identified as sig-
nificantly associated with GM volume. Third, backward 
elimination with bootstrap resampling analyses was 
again carried out, this time with the total PANSS score 
and the 3 PANSS subscale scores as dependent variables, 
and the 7 blood cell type counts, age, sex, years of educa-
tion, TBV, antipsychotic medication, tobacco smoking, 
cannabis smoking, and BMI, as predictors. Linear regres-
sion analyses of the individual items were then conducted 
only with those variables that emerged as significant in 
the model-generating procedure. Lastly, some additional 
analyses to rule out effects from potential confounders, 
such as nonantipsychotic medication or the use of mul-
tiple scanners, were conducted. Since all these analyses 
were mostly exploratory and hypothesis-generating, 
no correction for multiple comparisons was performed 
unless otherwise specified.30
Results
FEP and HC Comparison
Demographic and clinical data are described and com-
pared between FEP and HC in table 1. There were signif-
icant differences in years of education, and tobacco and 
cannabis smoking, but not in age, sex distribution, and 
BMI. Moreover, FEP had a smaller whole GM volume 
than HC, but larger global CSF, which included larger 
lateral (P = .023) and third (P = .010) ventricles. No dif-
ferences between groups were observed for WM (table 1). 
Concerning blood cells, neutrophil count was signifi-
cantly higher in FEP, whereas erythrocyte count was sig-
nificantly higher in HC. No other differences in blood cell 
count were found (table 2).
Blood Cells and Brain Volume
In FEP, neutrophil count was found to be significantly 
negatively associated with GM volume in 98.4% of the 
bootstrap samples, more than any other blood cell type. 
Subsequent regression analyses confirmed the significant 
association between neutrophil count and GM volume, 
and allowed us to identify the most parsimonious model, 
which included neutrophil count (β = −0.117, P < .001), 
age (β = −0.251, P < .001), and TBV (β = 0.818, P < .001). 
Neutrophils were also the most selected (89.2%) blood 
cell type in association with CSF volume, although in this 
case the association was positive. Once again, the final 
model included neutrophil count (β = 0.191, P = .007), 
age (β = 0.166, P = .018), and TBV (β = 0.641, P < .001). 
On the other hand, none of the blood cell types was signif-
icantly associated with WM, which showed associations 
only with age (β = 0.207, P < .001) and TBV (β = 0.892, 
P < .001). As for HC, only age and TBV were associated 
with GM and WM volume, while years of education and 
TBV were associated with CSF volume. None of the blood 
cell counts was significantly associated with GM, WM, or 
CSF in HC. Detailed information on all these analyses 
is available in the supplementary material. The whole-
brain VBM analysis in FEP showed neutrophil count to 
be consistently and specifically associated with reduced 
volumes of the right anterior insula, right temporal pole, 
right entorhinal area, right middle temporal gyrus, and 
right inferior temporal gyrus (figure 1 and supplementary 
table 1), after controlling for age and TBV. Afterwards, 
less specific linear regression analyses were conducted 
between neutrophil count and the whole volume of some 
brain regions, which included the aforementioned ones 
and additional brain regions that were identified in a 
less-restrictive VBM analysis (supplementary table  1). 
These analyses, which were carried out to search for more 
global effects, yet restricted to certain brain areas, showed 
neutrophil count to be associated with reduced whole 
bilateral volume of the thalamus (β = −0.211, P = .005), 
entorhinal area (β = −0.194, P =  .002), anterior insula 
(β = −0.133, P =  .019), among others, after controlling 
for age and TBV. Conversely, neutrophil count was asso-
ciated with larger lateral (β = 0.196, P = .010) and third 
(β = 0.152, P = .062) ventricles (figure 2 and table 3).
Blood Cells and Clinical Symptomatology
Neutrophil count was significantly directly associated 
with total PANSS score in 78.4% of the bootstrap sam-
ples, more than any other blood cell type. The subsequent 
regression analyses yielded a model that confirmed the sig-
nificant association between neutrophil count (β = 0.173, 
P  =  .038) and total PANSS score. Cannabis smoking 
(β = 0.245, P = .004) and years of education (β = −0.187, 
P = .030) were also significantly associated with the total 
PANSS score. Neutrophil count was also the most selected 
blood cell type in association with the positive (76.1%) and 
the general (75.7%) PANSS subscales. Additional regres-
sion analyses gave rise to the most parsimonious models, 
which included neutrophil count (β  =  0.166, P  =  .046), 
years of education (β = −0.218, P = .009), antipsychotic 
medication (β = −0.250, P = .003), and BMI (β = −0.200, 
P = .015) in association with the positive subscale, and neu-
trophil count (β = 0.152, P = .064) and cannabis smoking 
(β = 0.296, P < .001) in association with the general sub-
scale. Although the association between neutrophil count 
and the general subscale was seen to be at a trend-level, it 
was decided to include neutrophil count in the subsequent 
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analyses to further explore its potential association with 
the individual items of this subscale. On the other hand, 
no significant associations arose between any blood cell 
type and the negative PANSS subscale, which was only 
associated with years of education (β = −0.264, P = .002). 
Detailed information on these analyses is available in the 
supplementary material. Additional analyses of the indi-
vidual items of the positive and general subscales were 
carried out only with neutrophil count along with those 
variables that arose as significant in the previous analyses. 
These analyses revealed that neutrophil count was associ-
ated with the hallucinatory behavior (β = 0.182, P = .028), 
suspiciousness/persecution (β = 0.216, P = .010), hostility 
(β = 0.247, P = 0.005), disturbance of volition (β = 0.197, 
P = .018) and preoccupation (β = 0.283, P < .001) items 
(table 4).
Other Potential Confounders
To rule out potential confounding effects of the medi-
cations other than antipsychotics taken by FEP, all the 
dichotomous variables (yes/no) for each type of medica-
tion were included separately in all the analyses previously 
described. None of the previously reported associations 
between neutrophil count and brain volume and clin-
ical symptomatology was significantly altered by the 
Table 1. Demographic, Clinical Data, and Brain Tissue Volumes Are Compared Between First-Episode Psychosis (FEP) Patients and 
Healthy Control (HC) Participants
Variable FEP (n = 137) HC (n = 81) P value
Age (years) 23.03 (6.06) [13–35] 23.75 (5.59) [14–35] .381a
Sex 90 men/47 women 52 men/29 women .823b
Years of education 12.27 (3.36) [7–24] 14.52 (3.28) [6–23] <.001a
Ethnicity .733b
 Caucasian (no.) 122 70
 Hispanic (no.) 7 6
 Others (no.) 8 5
Antipsychotic medication (mg/day)c 41.62 (68.53) [0–319.93]
 Risperidone (yes/no) 51/86
 Olanzapine (yes/no) 43/94
 Paliperidone (yes/no) 19/118
 Aripiprazole (yes/no) 18/119
 Quetiapine (yes/no) 11/126
 Clozapine (yes/no) 7/130
 Amisulpride (yes/no) 6/131
 Ziprasidone (yes/no) 3/134
 Haloperidol (yes/no) 1/136
 Perphenazine (yes/no) 1/136
 Zuclopenthixol (yes/no) 1/136
Anxiolytics intake (yes/no) 40/97
Antidepressants intake (yes/no) 17/120
Lithium intake (yes/no) 10/127
Other mood stabilizers intake (yes/no) 5/132
Biperiden intake (yes/no) 18/119
Days from psychosis onset to scand 184.37 (121.62) [0–537]
Total PANSS score 67.54 (25.93) [30–158]
Positive PANSS score 16.47 (8.36) [7–41]
Negative PANSS score 16.74 (8.39) [7–43]
General PANSS score 34.34 (13.48) [16–82]
Body mass index 23.69 (4.02) [16.44–36.80] 23.37 (2.97) [17.63–30.74] .451e
Tobacco smoking (cigarettes/day) 7.72 (8.41) [0–40] 1.54 (3.84) [0–20] <.001e
Cannabis smoking (cigarettes/day) 1.45 (3.49) [0–20] 0.05 (0.22) [0–1] <.001e
Gray matter volume (mm3) 712.18 (81.54) [521.28–960.11] 726.99 (70.84) [575.61–929.01] .007f
White matter volume (mm3) 523.68 (65.81) [374.97–713.22] 530.47 (56.91) [382.35–691.34] .833f
Cerebrospinal fluid volume (mm3) 275.79 (42.69) [186.07–388.68] 269.57 (48.53) [178.98–373.65] .027f
Note: Data are expressed as mean (SD) [range]. Statistically significant differences are marked in bold.
aP value derived from a t-test.
bP value derived from a χ2 test.
cChlorpromazine equivalents estimation.
dTime between the date of onset of the first positive psychotic symptom, namely hallucinations or delusions (assessed with the Symptom 
Onset in Schizophrenia [SOS] scale) and the date of the scan.
eP value derived from an ANCOVA test controlling for age and sex.
fP value derived from an ANCOVA test controlling for age, sex, total brain volume, and years of education.
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inclusion of these variables. Even though lithium intake 
was significantly associated with increased GM volume 
(β  =  0.094, P  =  .003), the association between neutro-
phil count and GM volume remained intact (β = −0.121, 
P < .001). Furthermore, and to ensure that blood cell levels 
were not artificially increased in patients due to an acute 
infection, bivariate correlation analyses were performed 
analyzing neutrophil count between different temporal 
moments in which blood was sampled. Neutrophil count 
was significantly correlated between the baseline, 1-year, 
and 2-year extractions (baseline-1y [β = 0.375, P < .001]; 
baseline-2y [β = 0.417, P < .001]). Likewise, neutrophil 
count was still significantly increased in FEP with respect 
to HC after 2 years (FEP [n = 96]: 4.21 ± 1.46 × 109/L; 
HC [n = 61]: 3.41 ± 1.07 × 109/L, P < .001). Finally, since 
we observed that the participants scanned in one of the 
centers were significantly younger and less educated than 
the rest (supplementary material), we repeated the brain 
volume analyses excluding the participants from this cen-
ter to rule out potential confounding effects. The asso-
ciations between neutrophil count and GM (β = −0.100, 
P = .004) and CSF (β = 0.240, P = .001) volumes were 
still significant.
Discussion
This is the first study to show an association between 
reduced GM volume and neutrophil count in the con-
text of  a psychotic disorder. To the best of  our knowl-
edge, this is also among the first studies in which 
reduced brain tissue is associated with neutrophils in 
humans. Interestingly, reduction in GM was found to 
be accompanied by increased CSF volume. These GM 
and CSF changes were only observed in FEP and not 
in HC, and were associated only with the amount of 
neutrophils, and, expectedly, age and TBV. No other 
blood cell types showed an association. Interestingly, 
neutrophils were the only blood cell type to be signifi-
cantly increased in FEP when compared with HC. This 
is consistent with and extends a recent publication 
in which increased neutrophil count in nonsmoking, 
drug-naïve, FEP patients was reported.31 Conversely, 
erythrocyte count was found to be increased in HC 
with respect to FEP.
A thorough analysis of the GM regions showing 
reduced volume associated with neutrophils on patients 
indicated that reduced volume was generalized rather 
than localized, ie, it was observed all over the brain. 
While specific, consistent reduced GM was observed in 
the anterior insula, the temporal pole, the entorhinal 
area, and the middle and inferior temporal gyri of the 
right hemisphere, less specific volume decrease was found 
in several other brain regions or structures when con-
sidering their whole bilateral volume, namely, the thal-
amus, the entorhinal area, the precentral gyrus, and the 
left Heschl’s gyrus, among many others. Interestingly, 
neutrophil count was a better indicator of reduced vol-
ume than age in several regions. On the other hand, CSF 
was found to be increased in association with neutrophil 
count in FEP; the enlargement of the lateral and third 
ventricles seemed to account for most of this CSF incre-
ment. Altogether, this is suggestive of a volume tradeoff 
between GM and CSF. Actually, that enlarged ventricles 
are associated with GM loss in schizophrenia has been 
already reported,32,33 but Gaser et al33 observed that ven-
tricle enlargement was associated not only with diffuse 
brain atrophy, but also with the atrophy of adjacent struc-
tures, particularly the thalamus, which is consistent with 
our observation of reduced volumes of the thalamus and 
other GM regions not adjacent to the ventricles. Even 
though the global GM volume reduction is the most rel-
evant aspect of these results, it is worth mentioning that 
some of the regions whose reduced volume was associated 
with neutrophil count might be of special importance in 
psychosis. For example, the left Heschl’s gyrus shows a 
progressive deterioration over time in first-episode schiz-
ophrenia patients,34 and it appears to activate during 
auditory hallucinations in patients with schizophrenia.35
Although the observational nature of  this study does 
not allow us to conclude that neutrophils are causing 
brain tissue loss, neutrophils have been associated with 
larger infarct volumes after stroke,18,36,37 which is among 
the few indirect proofs available of  brain tissue loss 
associated with neutrophils in humans. There is more 
evidence available from studies with animals, such as 
that of  Kenne et al,17 who showed that early neutrophil 
depletion reduced tissue loss secondary to the injury in a 
mouse model of  traumatic brain injury. The importance 
of  neutrophils in the progression of  experimental auto-
immune encephalomyelitis, an animal model of  MS, has 
also been demonstrated.38 Other studies employing rat 
models of  traumatic brain injury and experimental auto-
immune encephalomyelitis have shown that neutrophils 
can gain access to the central nervous system by infil-
trating the choroid plexus of  the ventricles,39–41 which is 
Table 2. Leucocyte (×109/L), Erythrocyte (×1012/L), and Platelet 
(×109/L) Count Comparison Between First-Episode Psychosis 
Patients (FEP) and Healthy Control (HC) Participants, by Means 
of an ANCOVA Controlling for Age and Sex
Blood Cell FEP (n = 137) HC (n = 81) P Value
Neutrophils 4.08 (1.53) 3.66 (1.29) .025
Eosinophils 0.35 (0.77) 0.32 (0.50) .813
Basophils 0.06 (0.15) 0.09 (0.22) .308
Monocytes 0.71 (1.17) 0.52 (0.51) .198
Lymphocytes 2.22 (0.71) 2.20 (0.62) .892
Erythrocytes 4.74 (0.48) 4.87 (0.43) .007
Platelets 235.75 (51.48) 247.15 (52.70) .153
Note: Data are expressed as mean (SD). Uncorrected P values are 
presented. Statistically significant differences are marked in bold.
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consistent with the ventricle enlargement observed here. 
Similarly, some studies have reported accumulation of 
neutrophils in the central nervous system in mouse mod-
els of  the Alzheimer’s disease.42,43 In this regard, neutro-
phil depletion was shown to improve memory once the 
disease had started, and neutrophil blockade during the 
early stages of  the disease was associated with improved 
cognitive function later on.43 The present study repre-
sents, therefore, the first indirect proof  of  brain tissue 
loss associated with neutrophils in psychosis.
Higher neutrophil count was also associated with 
higher PANSS scores and, in particular, with some of the 
PANSS items from the positive and general subscales, 
such as hallucinatory behavior, suspiciousness, hostility, 
disturbance of volition, and preoccupation, among oth-
ers. It is important to note that avolition is considered as 
a core negative symptom in schizophrenia,44 although in 
the PANSS it is included in the general subscale instead 
of the negative subscale, which is probably inaccurate 
according to an analysis of the PANSS factor structure.45 
Therefore, neutrophil count appears to be a good indica-
tor of the severity of some of the most important symp-
toms presented by FEP and schizophrenia patients, such 
as hallucinations and avolition. Interestingly, more years 
of education and higher BMI were associated with less 
severity of some of the symptoms, which may be stud-
ied in depth by future studies, although similar results 
with BMI have been already published.46,47 Conversely, 
Fig. 1. Multiple basal slices are depicted showing the specific regions in which reduced volume was found to be associated with increased 
neutrophil count in first-episode psychosis, as identified in a voxel-based morphometry analysis employing an uncorrected voxel-level 
cluster defining threshold P <.001 and a family wise error-corrected cluster-level threshold P <.05. Top numbers indicate the “z” MNI 
coordinate. See supplementary table 1 for a list of these regions.
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cannabis smoking was associated with increased severity 
of several symptoms.
The role of neutrophils in chronic, and not only acute, 
inflammatory diseases, as well as in neurological disor-
ders such as MS or AD, has been an emerging research 
topic in recent years.14,48,49 Our results support the idea 
of a dysregulated immunological system in schizophre-
nia, in which neutrophils would be the principal actors 
of the immunological scene. The finding of a decreased 
erythrocyte count in FEP compared with HC, even 
though the mean erythrocyte count of patients is within 
the normal parameters, lends further support to the idea 
of immunological alterations.50 Moreover, if  we assume 
that neutrophils act against GM tissue, that would also 
support the autoimmune hypothesis in schizophrenia. 
Even though neutrophil count is increased in FEP as 
compared with HC, it is unlikely that this factor alone 
would explain why patient brains are affected by neutro-
phils whereas control brains are not. Rather, structural or 
functional impairments of the brain and/or the immune 
system could provide a better explanation for this appar-
ent neutrophil attack against its own host. For example, 
disruption of the BBB has been observed in MS and 
AD, and has been deemed as the probable cause of leu-
cocyte entry into the brain.51,52 Indeed, BBB disruption 
could be caused by neutrophils themselves.43 The BBB 
also appears to be disrupted in schizophrenia.15 Taken 
together, our results may reflect neutrophil infiltration 
in the brain through an impaired BBB, although this 
needs to be specifically corroborated in future studies. It 
is worth noting that some studies have shown an increase 
in BBB permeability in rats after acute stress exposure,53,54 
although other reports contradict previous findings (see, 
eg, the study by Roszkowski and Bohacek).55 Therefore, 
stress may be an important factor to be considered as 
potentially responsible for BBB alterations. In addition, 
increased numbers of neutrophils have been seen both in 
humans and in mice exposed to chronic stress.56
Fig. 2. (A) Anterolateral and (B) posterolateral views of a 3-dimensional schematic representation of the brain regions whose whole 
volume was found reduced in first-episode psychosis (FEP) patients associated with increased neutrophil count, except the lateral 
ventricles, which were found enlarged in association with higher neutrophil count. In C, scatter plots for FEP patients depicting the 
volume reduction of the most relevant regions are presented. See table 3 and supplementary table 1 for more information.
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Overall, considering the results from our study and 
from previous literature together,38,42,43 a common mech-
anism in the etiology of schizophrenia, MS, and AD 
may be implied, in which neutrophils act as triggers, or 
one of the most important triggers, of tissue loss from 
the initial stages of the disease, leading to subsequent 
cognitive and clinical decline. Recent reports of a com-
mon spatial pattern of brain abnormalities between AD 
and adolescent-onset schizophrenia patients,57 as well 
as the finding that patients with schizophrenia are at a 
higher risk of developing dementia,58 give support to the 
hypothesis of shared causative mechanisms between AD 
and schizophrenia. Moreover, several etiological similari-
ties between MS and schizophrenia have been found,59 as 
well as an increased probability of MS patients develop-
ing schizophrenia.59
Importantly, we carefully examined the impact of 
potential confounders that may alter neutrophils, such as 
antipsychotic medication,60 other psychotropic medica-
tions such as lithium,61,62 BMI, and tobacco or cannabis 
smoking, since a delay in spontaneous neutrophil death as 
a consequence of cigarette smoke and nicotine has been 
observed.63 None of these factors affected the reported 
associations between neutrophil count and brain volume 
or clinical symptomatology, even though lithium intake 
was associated with increased GM volume in patients, 
as has been previously reported in healthy people64 and 
bipolar patients.65 Another important factor that we 
considered is acute infection, since it could increase blood 
cell count at a particular moment. However, since neu-
trophil count remained stable and increased in FEP with 
respect to HC 2 years after the initial blood assessment, 
it is highly unlikely that an acute infection could explain 
any of the results presented.
In light of all this, neutrophil count could be postu-
lated as an indicator or potential biomarker of FEP and 
schizophrenia severity. This indicator would have the 
advantage of being inexpensive and handy, as it can be 
quantified with a single blood sampling. Altogether, these 
results open the door to some therapeutic options con-
cerning neutrophils that have already been proposed for 
other conditions, such as neutrophil depletion or block-
ing neutrophil entry into the brain.18,49 Further research 
should assess whether therapies of this kind could poten-
tially improve the course of the psychotic disorder or even 
stop its progression. More research is needed to replicate 
our results, including the specific brain areas showing 
reduced volume associated with neutrophils, and which 
particular consequences it may have. Moreover, future 
studies may also address many unresolved questions aris-
ing from the present results; eg, whether there are spe-
cific subtypes of the disease, or age of onset subgroups, in 
which the association between neutrophils and brain vol-
ume and/or clinical symptomatology is particularly rele-
vant; whether there are other blood cell types directly or 
indirectly involved in this framework, eg, by amplifying 
Table 3. Linear Regression Analyses Between Neutrophil Count and the Whole Volume of Some Relevant Brain Regions of First-
Episode Psychosis Patients That Were Identified in Previous Voxel-Based Morphometry Analyses
Brain Area Neutrophil Count Age Total Brain Volume R2 F Test P Value
Gray matter
 Entorhinal area −0.194*** (FDR) −0.044 0.641**** .512 46.585 <.001
 Inferior temporal gyrus −0.127*** (FDR) −0.149**** 0.812**** .792 168.527 <.001
 Temporal pole −0.168*** (FDR) −0.134** 0.688**** .609 68.966 <.001
 Precentral gyrus −0.157*** (FDR) −0.171*** 0.705**** .652 82.891 <.001
 Thalamus −0.211*** (FDR) −0.111 0.449**** .324 21.244 <.001
 Middle temporal gyrus −0.117*** (FDR) −0.206**** 0.789**** .787 163.769 <.001
 Superior frontal gyrus −0.114*** (FDR) −0.307**** 0.731**** .774 151.829 <.001
 Left Heschl’s gyrus −0.170** (FDR) −0.027 0.610**** .450 36.279 <.001
 Occipital fusiform gyrus −0.149** (FDR) −0.120* 0.678**** .573 59.512 <.001
 Anterior insula −0.133** (FDR) −0.113* 0.710**** .608 68.805 <.001
 Lingual gyrus −0.135* (FDR) −0.149** 0.658**** .553 54.825 <.001
 Cerebellum −0.132* (FDR) −0.211**** 0.616**** .534 50.720 <.001
 Frontal operculum −0.130* (FDR) −0.175*** 0.631**** .529 49.729 <.001
 Postcentral gyrus −0.114† −0.235**** 0.644**** .580 61.210 <.001
 Superior temporal gyrus −0.061 −0.262**** 0.745**** .727 117.766 <.001
 Posterior cingulate cortex −0.038 −0.220**** 0.732**** .662 86.904 <.001
Cerebrospinal fluid
 Lateral ventricles 0.196*** (FDR) −0.009 0.543**** .293 18.379 <.001
 Third ventricle 0.152+ 0.044 0.448**** .194 10.680 <.001
 Fourth ventricle 0.129 −0.053 0.460**** .215 12.114 <.001
Note: Along with neutrophil count, age and total brain volume were included as additional predictors to control for their effects. See 
figure 2 and supplementary table 1 for further information. (FDR) = significant after correcting for multiple comparisons with the 
Benjamini–Hochberg procedure. Statistically significant associations are marked in bold.
+P = .062; †P = .051; *P < .05; **P < .025; ***P ≤ .01; ****P < .001.
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neutrophil response; and, finally, the impact of substance 
use. Although here we examined the effects of tobacco 
and cannabis smoking, patients with schizophrenia and 
FEP tend to be heavy smokers,66 and even if  we assume 
that smoking does not have a direct impact on amplifying 
the neutrophil immune response, increasing the amount 
of circulating neutrophils, in a context in which some-
thing is not working properly, would only aggravate the 
condition.
This study presents some noteworthy strengths. First, 
the sample employed was relatively large and homogene-
ous in regard to illness duration, therefore providing more 
reliability and generalizability to our findings. Second, 
antipsychotic medication information was thoroughly 
collected and its potential effects on brain volume or 
neutrophils were controlled; other potentially confound-
ing factors, such as other psychotropic medications, sex, 
BMI, and tobacco and cannabis smoking, were con-
trolled as well. Third, we assessed brain changes employ-
ing a whole-brain approach, which allowed us to analyze 
GM and CSF volume changes in an unbiased manner. 
Conversely, some limitations should also be noted. First, 
this was an observational study, meaning that we were 
not able to manipulate the independent variable, and 
cause–effect relationships cannot be inferred. Second, 
MRI acquisition and blood sampling were not necessar-
ily carried out the same day; moreover, MRI acquisitions 
were conducted on 5 different scanners and this might 
have biased the results. Third, while the effects of anti-
psychotic medication were controlled for, we did not have 
information on the precise dosage of other psychotropic 
medications. Fourth, information on anti-inflammatory 
medication use, inflammatory diseases, and sleep-related 
problems, which could have altered neutrophil count, 
were not recorded. Finally, this was an exploratory study, 
and we lacked information on more precise inflammatory 
markers.
In conclusion, we show, for the first time, an association 
between neutrophil count and reduced GM tissue in FEP. 
Neutrophil count was also associated with increased CSF 
volume and higher scores in the total PANSS and sev-
eral relevant items, such as those assessing hallucinations 
and avolition. These results suggest that the immunolog-
ical system of patients with schizophrenia and related 









Medication BMI R2 F test P Value
Total PANSS 0.173* 0.245*** −0.187** — — .136 6.966 <.001
Positive PANSS subscale 0.166* — −0.218*** −0.250*** −0.200** .160 6.281 <.001
 P1. Delusions ns — −0.198** −0.316**** −0.169* .167 6.608 <.001
 P2. Conceptual disorganization 0.163† — −0.174* −0.212** −0.207** .132 5.008 <.001
 P3. Hallucinatory behavior 0.182* — −0.292**** ns −0.238*** .168 6.642 <.001
 P4. Excitement ns — ns −0.213** ns .068 2.405 .053
 P5. Grandiosity ns — ns ns ns — — —
 P6. Suspiciousness/persecution 0.216*** — −0.240*** −0.223*** ns .143 5.491 <.001
 P7. Hostility 0.247*** — ns ns ns .062 2.191 .073
Negative PANSS subscale — — −0.264*** — — .070 10.142 .002
General PANSS subscale 0.152+ 0.296**** — — — .111 8.404 <.001
 G1. Somatic concern ns ns — — — — — —
 G2. Anxiety ns 0.182* — — — .043 2.978 .054
 G3. Guilt feelings ns ns — — — — — —
 G4. Tension ns 0.259*** — — — .082 5.999 .003
 G5. Mannerisms and posturing 0.160† 0.169* — — — .055 3.872 .023
 G6. Depression ns ns — — — — — —
 G7. Motor retardation ns 0.218*** — — — .066 4.751 .010
 G8. Uncooperativeness ns 0.234*** — — — .058 4.094 .019
 G9. Unusual thought content ns 0.220*** — — — .068 4.914 .009
 G10. Disorientation ns 0.345**** — — — .126 9.694 <.001
 G11. Poor attention ns 0.209** — — — .056 3.980 .021
 G12. Lack of judgment and insight ns ns — — — — — —
 G13. Disturbance of volition 0.197** 0.244*** — — — .099 7.382 <.001
 G14. Poor impulse control ns 0.288**** — — — .090 6.599 .002
 G15. Preoccupation 0.283**** 0.188** — — — .117 8.848 <.001
 G16. Active social avoidance ns 0.172* — — — .035 2.452 .090
Note: The analysis of the individual items of the positive PANSS subscale included neutrophil count, years of education, antipsychotic 
medication, and BMI as predictors. The analysis of the individual items of the general PANSS subscale included neutrophil count 
and cannabis smoking as predictors. Uncorrected P values are presented. Statistically significant associations are marked in bold. ns, 
nonsignificant.
+P = .064; †P < .06; *P < .05; **P < .025; ***P ≤ .01; ****P < .001.
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disorders is dysregulated, and appear to give support to 
the autoimmune hypothesis. Neutrophil count is pro-
posed as an indicator of psychosis severity, and may give 
rise to new therapeutic options addressing neutrophils or 
the neutrophil immune response.
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Supplementary data are available at Schizophrenia 
Bulletin online.
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